P53,bcl-2, Nm 23 Expression in Mucinous Ovarian Tumors and Relationship of This Expression With Histopathological Parameters

Turkiye Klinikleri Journal of Medical Sciences - Turkey
doi 10.5336/medsci.2010-19266
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Turkiye Klinikleri

Related search

Expression of C-Myc and Mutation of the KRAS Gene in Patients With Ovarian Mucinous Tumors

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2015English

Long Term Lithium Treatment Suppresses P53 and Bax Expression but Increases BCL-2 Expression

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1999English

Ki-67, P53, BCL-2 and Bax Expression in Urothelial Carcinomas of Urinary Bladder

Turk Patoloji Dergisi
Forensic MedicinePathology
2010English

BCL-2 Over-Expression in Urothelial Tumors of the Bladder. An Immunohistochemical Study

Annals of the College of Medicine, Mosul
2018English

P53 Expression in Human Small-Intestinal Tumors

Oncology Reports
MedicineCancer ResearchOncology
1994English

P53 and BCL-2 Expression Do Not Correlate With Prognosis in Primary Cutaneous Large T-Cell Lymphomas

Journal of Cutaneous Pathology
DermatologyForensic MedicinePathologyHistology
1997English

Expression of the BCL-3 Proto-Oncogene Suppresses P53 Activation

Genes and Development
GeneticsDevelopmental Biology
2006English

Evaluation of BCL-2 Expression in Cigarette Smokers

Egyptian Dental Journal
2017English

Gene Expression Patterns in the Histopathological Classification of Epithelial Ovarian Cancer

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy